| 摘要 |
The present invention provides compounds of formula (I)wherein R<1>, R<2>, R<3 >and R<4 >are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
|
